Source: Medical Buyer

Librede: Lygos Acquires Librede To Accelerate Cannabinoid, Nutraceutical Products

BERKELEY, Calif.-(BUSINESS WIRE)- Lygos, Inc., a full-stack provider of sustainable specialty chemicals that deliver high-value performance without environmental toxicity, today announced the acquisition of Librede, Inc., an emerging synthetic biology company...Read More

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Jason Poulos's photo - Co-Founder & CEO of Librede

Co-Founder & CEO

Jason Poulos

CEO Approval Rating

81/100

Read more